I believe you may be right koro - if either of the trials are positive then it PAA may be a potential take over opportunity for novartis.
I believe (if we hold) we'll be looking at x2 to x4 gain if either ANN regarding trials is positive AND then a further x2 to x4 gains pre-march ANN
This ones about get interesting
Ann: Research Collaboration & Joint Patent with Japanese Company, page-37
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.005(2.78%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $43.18K | 243.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 70085 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 256095 | 5 |
View Market Depth
| Last trade - 12.41pm 13/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |